AETERNUM HEALTH, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $203.7K | $65.1K | $20.1K | $5.0K | — | — | — |
| Cost of Revenue | — | — | $49.4K | $43.6K | — | — | — | — |
| Gross Profit | — | $120.1K | $-12.7K | $-33.0K | — | — | — | — |
| Gross Margin | — | 58.9% | -19.5% | -164.2% | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $105.3K | $99.8K | $335.5K | $229.5K | $12.7K | $3.8K | $17.3K |
| Operating Income | — | $-269.3K | $-430.5K | $-552.4K | $-304.0K | $-26.5K | $-41.4K | $-60.4K |
| Operating Margin | — | -132.2% | -661.1% | -2,746.8% | -6,080.7% | — | — | — |
| Interest Expense | — | $67.8K | $69.8K | $80.6K | $1.7M | — | — | $762 |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | $0 | — | — | — |
| Net Income | — | $-337.1K | $-450.3K | $-632.9K | $-2.1M | $-26.5K | $-41.4K | $-61.1K |
| Net Margin | — | -165.5% | -691.5% | -3,147.6% | -41,467.8% | — | — | — |
| EPS (Basic) | — | $-0.01 | $-0.01 | $-0.01 | $-0.05 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | — | $-0.01 | $-0.01 | $-0.01 | $-0.05 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 52.2M | 49.0M | 48.5M | 42.5M | 40.3M | 24.6M | — | — |
| Shares Outstanding (Diluted) | 52.2M | 49.0M | 48.5M | 42.5M | 40.3M | 24.6M | — | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |